IPW
ABBV icon

Inlet Private Wealth’s AbbVie ABBV Stock Holding History

Inlet Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Sell
14,801
-1,600
-10% -$355K 0.82% 42
2025
Q4 		$3.75M Sell
16,401
-600
-4% -$137K 0.87% 40
2025
Q3 		$3.94M Buy
17,001
+47
+0.3% +$9.57K 0.89% 37
2025
Q2 		$3.15M Hold
16,954
– – 0.77% 41
2025
Q1 		$3.55M Hold
16,954
– – 0.92% 39
2024
Q4 		$3.01M Buy
16,954
+487
+3% +$89.5K 0.8% 44
2024
Q3 		$3.25M Hold
16,467
– – 0.83% 43
2024
Q2 		$2.82M Buy
16,467
+500
+3% +$82.8K 0.77% 42
2024
Q1 		$2.91M Sell
15,967
-10
-0.1% -$1.72K 0.81% 42
2023
Q4 		$2.48M Sell
15,977
-400
-2% -$58.3K 0.76% 41
2023
Q3 		$2.44M Sell
16,377
-13,047
-44% -$1.92M 0.8% 46
2023
Q2 		$3.96M Buy
29,424
+411
+1% +$60.3K 1% 30
2023
Q1 		$4.62M Sell
29,013
-300
-1% -$45.9K 1.2% 25
2022
Q4 		$4.74M Sell
29,313
-366
-1% -$56.1K 1.22% 23
2022
Q3 		$3.98M Buy
29,679
+401
+1% +$57.5K 1.19% 26
2022
Q2 		$4.48M Sell
29,278
-93
-0.3% -$14.2K 1.28% 24
2022
Q1 		$4.76M Buy
29,371
+215
+0.7% +$31.2K 1.19% 23
2021
Q4 		$3.95M Buy
29,156
+67
+0.2% +$7.91K 0.96% 39
2021
Q3 		$3.14M Hold
29,089
– – 0.84% 45
2021
Q2 		$3.28M Buy
29,089
+44
+0.2% +$4.96K 0.86% 46
2021
Q1 		$3.14M Buy
29,045
+2,019
+7% +$216K 0.9% 45
2020
Q4 		$2.9M Buy
27,026
+2,150
+9% +$207K 0.95% 40
2020
Q3 		$2.18M Hold
24,876
– – 0.85% 42
2020
Q2 		$2.44M Buy
24,876
+121
+0.5% +$10.7K 0.97% 39
2020
Q1 		$1.89M Buy
24,755
+2,300
+10% +$196K 0.87% 41
2019
Q4 		$1.99M Buy
22,455
+5,273
+31% +$438K 0.66% 46
2019
Q3 		$1.3M Buy
17,182
+2,000
+13% +$137K 0.48% 62
2019
Q2 		$1.07M Buy
15,182
+200
+1% +$15.7K 0.38% 72
2019
Q1 		$1.21M Buy
14,982
+7,100
+90% +$581K 0.49% 61
2018
Q4 		$727K Buy
+7,882
New +$693K 0.39% 63

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Inlet Private Wealth's ABBV Position: Q1 2026 in Review

Inlet Private Wealth reduced its AbbVie (ABBV) stake by 9.8% in Q1 2026, selling an estimated $355K and leaving 14,801 shares worth $3.22M. The position accounts for 0.82% of the portfolio, ranked #42.

Inlet Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.76M in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Inlet Private Wealth held 14,801 shares of AbbVie worth $3.22M as of Q1 2026.
  • Inlet Private Wealth sold 1,600 AbbVie shares in Q1 2026, an estimated $355K.
  • AbbVie made up 0.82% of Inlet Private Wealth's portfolio in Q1 2026, its #42 holding.
  • Inlet Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
  • Inlet Private Wealth's AbbVie position peaked at $4.76M in Q1 2022.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Inlet Private Wealth's 13F filing for Q1 2026, filed 13 May 2026.